Ken Research Logo

Uae Clinical Nutrition Diabetes Care Market Report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

UAE Clinical Nutrition Diabetes Care Market is worth USD 14 million, fueled by increasing diabetes cases and advancements in specialized nutritional products.

Region:Middle East

Author(s):Shubham

Product Code:KRAD5429

Pages:86

Published On:December 2025

About the Report

Base Year 2024

UAE Clinical Nutrition Diabetes Care Market Overview

  • The UAE Clinical Nutrition Diabetes Care Market is valued at USD 14 million, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of diabetes, rising healthcare expenditure, and a growing awareness of the importance of nutrition in diabetes management. The market is also supported by advancements in nutritional science, the development of specialized products tailored for diabetic patients, increasing availability of diabetes-specific nutrition products, and collaborations between healthcare providers and nutritionists.
  • Key cities dominating the market include Dubai and Abu Dhabi, which are known for their advanced healthcare infrastructure and high concentration of specialized diabetes care centers. The presence of a large expatriate population and increasing lifestyle-related health issues further contribute to the demand for clinical nutrition products in these regions.
  • The National Obesity Health and Clinical Intervention Guidelines, 2024 issued by the Ministry of Health and Prevention (MoHAP), provide a comprehensive framework for managing diabetes-related conditions through nutrition interventions, requiring healthcare providers to integrate clinical nutrition plans with standards for glycemic control, personalized dietary assessments, and mandatory screening for high-risk patients in all public and private facilities.
UAE Clinical Nutrition Diabetes Care Market Size

UAE Clinical Nutrition Diabetes Care Market Segmentation

By Product Type:The product type segmentation includes various specialized nutritional products designed for diabetes management. The subsegments are Diabetes-specific Oral Nutritional Supplements (ONS), Diabetes-specific Enteral Nutrition (tube feeding) Formulas, Parenteral Nutrition for Patients with Diabetes, Diabetes-friendly Meal Replacement Powders & RTD Drinks, Low-GI / Sugar-controlled Medical Foods & Snacks, and Others (vitamin & mineral blends, amino acid formulas, etc.). Among these, Diabetes-specific Oral Nutritional Supplements (ONS) are leading the market due to their convenience and effectiveness in managing blood sugar levels.

UAE Clinical Nutrition Diabetes Care Market segmentation by Product Type.

By End-User:The end-user segmentation encompasses various healthcare settings where clinical nutrition products are utilized. This includes Tertiary Care Hospitals & Specialized Diabetes Centers, General Hospitals & Clinics, Homecare & Outpatient Nutrition Programs, Long-term Care & Rehabilitation Facilities, and Retail / Self-pay Consumers. Tertiary Care Hospitals & Specialized Diabetes Centers dominate this segment due to their comprehensive diabetes management programs and access to specialized nutrition products.

UAE Clinical Nutrition Diabetes Care Market segmentation by End-User.

UAE Clinical Nutrition Diabetes Care Market Competitive Landscape

The UAE Clinical Nutrition Diabetes Care Market is characterized by a dynamic mix of regional and international players. Leading participants such as Abbott Laboratories (Abbott Nutrition), Nestlé Health Science, Danone Nutricia, Fresenius Kabi, B. Braun Melsungen AG, Mead Johnson Nutrition (Reckitt), Ajinomoto Group, Otsuka Pharmaceutical Co., Ltd., Baxter International Inc., AYMES International Ltd., Nutricia Middle East DMCC, Abbott Laboratories S.A. (Middle East & UAE operations), Nestlé Middle East FZE, Fresenius Kabi Gulf FZ LLC, Local & Regional Players (e.g., Gulf Pharmaceutical Industries – Julphar) contribute to innovation, geographic expansion, and service delivery in this space.

Abbott Laboratories

1888

Chicago, USA

Nestlé Health Science

2011

Lausanne, Switzerland

Danone Nutricia

1896

Paris, France

Fresenius Kabi

1999

Bad Homburg, Germany

B. Braun Melsungen AG

1839

Melsungen, Germany

Company

Establishment Year

Headquarters

UAE Diabetes Nutrition Revenue (USD million)

UAE Diabetes Nutrition Revenue Growth Rate (CAGR %)

Market Share in UAE Clinical Nutrition for Diabetes Care (%)

Portfolio Breadth in Diabetes?specific Clinical Nutrition (number of SKUs)

Share of Institutional vs Retail Sales (%)

Average Realized Price per Unit (AED per liter/kg)

UAE Clinical Nutrition Diabetes Care Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Diabetes:The UAE has one of the highest diabetes prevalence rates globally, with approximately 1.3 million adults diagnosed as of 2023. This alarming statistic, representing about 18.3% of the adult population, drives demand for clinical nutrition solutions tailored for diabetes management. The World Health Organization projects that in future, diabetes cases in the UAE could rise to 1.5 million, further emphasizing the urgent need for effective nutritional interventions.
  • Rising Awareness of Clinical Nutrition:Public awareness campaigns and educational initiatives have significantly increased knowledge about the role of nutrition in diabetes management. In 2023, over 60% of the population reported understanding the importance of dietary choices in controlling diabetes. This growing awareness is supported by government health programs, which allocated AED 50 million for diabetes education, fostering a proactive approach to health and nutrition among citizens and residents.
  • Government Initiatives Promoting Health and Wellness:The UAE government has implemented various health initiatives, including the National Diabetes Strategy, which aims to reduce diabetes prevalence by 20% in future. In 2023, the government invested AED 100 million in health promotion programs, focusing on preventive care and nutrition. These initiatives not only enhance public health but also create a favorable environment for clinical nutrition services, driving market growth in diabetes care.

Market Challenges

  • High Cost of Specialized Nutrition Products:The cost of specialized nutrition products for diabetes management can be prohibitive, with prices ranging from AED 150 to AED 500 per month. This financial barrier limits access for many patients, particularly those in lower-income brackets. As of 2023, approximately 30% of the diabetic population reported difficulties affording necessary nutritional products, hindering effective diabetes management and care.
  • Limited Access to Healthcare Facilities in Remote Areas:In the UAE, healthcare access remains uneven, particularly in rural regions where only 40% of healthcare facilities are located. This disparity affects the availability of clinical nutrition services, with many patients unable to receive timely nutritional guidance. As of 2023, around 25% of the diabetic population in remote areas reported insufficient access to healthcare resources, complicating their management of the condition.

UAE Clinical Nutrition Diabetes Care Market Future Outlook

The future of the UAE Clinical Nutrition Diabetes Care Market appears promising, driven by technological advancements and a growing emphasis on personalized healthcare. As telehealth services expand, patients will gain easier access to nutrition consultations, enhancing their management of diabetes. Additionally, the integration of artificial intelligence in developing personalized nutrition plans is expected to revolutionize patient care, ensuring tailored dietary recommendations that align with individual health needs and preferences.

Market Opportunities

  • Expansion of Telehealth Services:The rise of telehealth services presents a significant opportunity for the clinical nutrition market. With over 70% of the population using smartphones, remote consultations can enhance access to nutritionists, particularly for those in underserved areas. This shift could lead to a 30% increase in patient engagement in nutrition programs in future, improving diabetes management outcomes.
  • Development of Personalized Nutrition Plans:The demand for personalized nutrition plans is on the rise, with 65% of patients expressing interest in tailored dietary solutions. By leveraging data analytics and genetic information, healthcare providers can create customized nutrition strategies that cater to individual metabolic profiles. This trend is expected to drive a 25% increase in the adoption of personalized nutrition services in future, enhancing patient satisfaction and health outcomes.

Scope of the Report

SegmentSub-Segments
By Product Type

Diabetes?specific Oral Nutritional Supplements (ONS)

Diabetes?specific Enteral Nutrition (tube feeding) Formulas

Parenteral Nutrition for Patients with Diabetes

Diabetes?friendly Meal Replacement Powders & RTD Drinks

Low?GI / Sugar?controlled Medical Foods & Snacks

Others (vitamin & mineral blends, amino acid formulas, etc.)

By End-User

Tertiary Care Hospitals & Specialized Diabetes Centers

General Hospitals & Clinics

Homecare & Outpatient Nutrition Programs

Long-term Care & Rehabilitation Facilities

Retail / Self-pay Consumers

By Distribution Channel

Institutional Sales (hospitals, clinics, long-term care)

Hospital & Chain Pharmacies

Community Pharmacies & Drug Stores

Modern Grocery Retail (Supermarkets/Hypermarkets)

E-commerce & Online Pharmacies

Others

By Patient Demographics

Pediatric Patients with Diabetes

Adult Patients with Diabetes

Geriatric Patients with Diabetes

High?BMI / Obese Diabetic Patients

Others

By Diabetes Type / Clinical Condition

Type 1 Diabetes

Type 2 Diabetes

Gestational Diabetes

Pre-diabetes & Impaired Glucose Tolerance

Diabetes with Co-morbidities (CKD, CVD, etc.)

Others

By Product Formulation & Nutritional Profile

Low Glycemic Index (Low?GI) Formulations

High?Protein / High?Fiber Formulations

Sugar?Free / No Added Sugar Formulations

Gluten-Free & Lactose-Free Formulations

Specialized Formulas for Renal / Cardio?metabolic Complications

Organic / Clean?label Formulations

Others

By Packaging Type

Bottles & Ready?to?Drink (RTD) Packs

Sachets & Stick Packs

Tetra Packs / Cartons

Cans

Bulk Institutional Packs

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Health and Prevention, Dubai Health Authority)

Healthcare Providers and Clinics

Pharmaceutical Companies

Nutrition Product Manufacturers

Health Insurance Companies

Medical Device Manufacturers

Health and Wellness Organizations

Players Mentioned in the Report:

Abbott Laboratories (Abbott Nutrition)

Nestle Health Science

Danone Nutricia

Fresenius Kabi

B. Braun Melsungen AG

Mead Johnson Nutrition (Reckitt)

Ajinomoto Group

Otsuka Pharmaceutical Co., Ltd.

Baxter International Inc.

AYMES International Ltd.

Nutricia Middle East DMCC

Abbott Laboratories S.A. (Middle East & UAE operations)

Nestle Middle East FZE

Fresenius Kabi Gulf FZ LLC

Local & Regional Players (e.g., Gulf Pharmaceutical Industries Julphar)

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. UAE Clinical Nutrition Diabetes Care Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 UAE Clinical Nutrition Diabetes Care Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. UAE Clinical Nutrition Diabetes Care Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of diabetes
3.1.2 Rising awareness of clinical nutrition
3.1.3 Government initiatives promoting health and wellness
3.1.4 Advancements in nutritional products and services

3.2 Market Challenges

3.2.1 High cost of specialized nutrition products
3.2.2 Limited access to healthcare facilities in remote areas
3.2.3 Regulatory hurdles in product approvals
3.2.4 Competition from alternative therapies

3.3 Market Opportunities

3.3.1 Expansion of telehealth services
3.3.2 Development of personalized nutrition plans
3.3.3 Collaborations with healthcare providers
3.3.4 Growth in e-commerce for nutrition products

3.4 Market Trends

3.4.1 Increasing demand for plant-based nutrition
3.4.2 Focus on preventive healthcare
3.4.3 Integration of technology in nutrition management
3.4.4 Rise of functional foods and supplements

3.5 Government Regulation

3.5.1 Food safety regulations
3.5.2 Labeling requirements for nutritional products
3.5.3 Guidelines for health claims on products
3.5.4 Regulations on advertising and marketing of health products

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. UAE Clinical Nutrition Diabetes Care Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. UAE Clinical Nutrition Diabetes Care Market Segmentation

8.1 By Product Type

8.1.1 Diabetes?specific Oral Nutritional Supplements (ONS)
8.1.2 Diabetes?specific Enteral Nutrition (tube feeding) Formulas
8.1.3 Parenteral Nutrition for Patients with Diabetes
8.1.4 Diabetes?friendly Meal Replacement Powders & RTD Drinks
8.1.5 Low?GI / Sugar?controlled Medical Foods & Snacks
8.1.6 Others (vitamin & mineral blends, amino acid formulas, etc.)

8.2 By End-User

8.2.1 Tertiary Care Hospitals & Specialized Diabetes Centers
8.2.2 General Hospitals & Clinics
8.2.3 Homecare & Outpatient Nutrition Programs
8.2.4 Long-term Care & Rehabilitation Facilities
8.2.5 Retail / Self-pay Consumers

8.3 By Distribution Channel

8.3.1 Institutional Sales (hospitals, clinics, long-term care)
8.3.2 Hospital & Chain Pharmacies
8.3.3 Community Pharmacies & Drug Stores
8.3.4 Modern Grocery Retail (Supermarkets/Hypermarkets)
8.3.5 E-commerce & Online Pharmacies
8.3.6 Others

8.4 By Patient Demographics

8.4.1 Pediatric Patients with Diabetes
8.4.2 Adult Patients with Diabetes
8.4.3 Geriatric Patients with Diabetes
8.4.4 High?BMI / Obese Diabetic Patients
8.4.5 Others

8.5 By Diabetes Type / Clinical Condition

8.5.1 Type 1 Diabetes
8.5.2 Type 2 Diabetes
8.5.3 Gestational Diabetes
8.5.4 Pre-diabetes & Impaired Glucose Tolerance
8.5.5 Diabetes with Co-morbidities (CKD, CVD, etc.)
8.5.6 Others

8.6 By Product Formulation & Nutritional Profile

8.6.1 Low Glycemic Index (Low?GI) Formulations
8.6.2 High?Protein / High?Fiber Formulations
8.6.3 Sugar?Free / No Added Sugar Formulations
8.6.4 Gluten-Free & Lactose-Free Formulations
8.6.5 Specialized Formulas for Renal / Cardio?metabolic Complications
8.6.6 Organic / Clean?label Formulations
8.6.7 Others

8.7 By Packaging Type

8.7.1 Bottles & Ready?to?Drink (RTD) Packs
8.7.2 Sachets & Stick Packs
8.7.3 Tetra Packs / Cartons
8.7.4 Cans
8.7.5 Bulk Institutional Packs
8.7.6 Others

9. UAE Clinical Nutrition Diabetes Care Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 UAE Diabetes Nutrition Revenue (USD million)
9.2.3 UAE Diabetes Nutrition Revenue Growth Rate (CAGR %)
9.2.4 Market Share in UAE Clinical Nutrition for Diabetes Care (%)
9.2.5 Portfolio Breadth in Diabetes?specific Clinical Nutrition (number of SKUs)
9.2.6 Share of Institutional vs Retail Sales (%)
9.2.7 Average Realized Price per Unit (AED per liter/kg)
9.2.8 Geographic Coverage within UAE (number of emirates / facilities served)
9.2.9 Number of Key Hospital / Diabetes Center Tie?ups in UAE
9.2.10 R&D / Innovation Intensity (% of revenue spent on R&D)
9.2.11 Regulatory & Quality Compliance Footprint (MOHAP / DHA / international certifications)
9.2.12 Brand Awareness & Preference among Diabetic Patients (index score)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Abbott Laboratories (Abbott Nutrition)
9.5.2 Nestlé Health Science
9.5.3 Danone Nutricia
9.5.4 Fresenius Kabi
9.5.5 B. Braun Melsungen AG
9.5.6 Mead Johnson Nutrition (Reckitt)
9.5.7 Ajinomoto Group
9.5.8 Otsuka Pharmaceutical Co., Ltd.
9.5.9 Baxter International Inc.
9.5.10 AYMES International Ltd.
9.5.11 Nutricia Middle East DMCC
9.5.12 Abbott Laboratories S.A. (Middle East & UAE operations)
9.5.13 Nestlé Middle East FZE
9.5.14 Fresenius Kabi Gulf FZ LLC
9.5.15 Local & Regional Players (e.g., Gulf Pharmaceutical Industries – Julphar)

10. UAE Clinical Nutrition Diabetes Care Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation for Diabetes Care
10.1.2 Preferred Suppliers and Products
10.1.3 Evaluation Criteria for Procurement
10.1.4 Contracting Processes

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Health Infrastructure
10.2.2 Spending on Nutrition Programs
10.2.3 Partnerships with Nutrition Providers
10.2.4 Budgeting for Employee Wellness

10.3 Pain Point Analysis by End-User Category

10.3.1 Challenges Faced by Hospitals
10.3.2 Issues in Homecare Settings
10.3.3 Barriers for Long-term Care Facilities
10.3.4 Needs of Clinics

10.4 User Readiness for Adoption

10.4.1 Awareness Levels of Nutrition Products
10.4.2 Training Needs for Healthcare Providers
10.4.3 Acceptance of New Technologies
10.4.4 Feedback Mechanisms

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of Health Outcomes
10.5.2 Cost Savings Analysis
10.5.3 User Satisfaction Surveys
10.5.4 Opportunities for Product Expansion

11. UAE Clinical Nutrition Diabetes Care Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail vs Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV, Greenfield, M&A, Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of published reports from health organizations and government health ministries in the UAE
  • Review of academic journals and articles focusing on clinical nutrition and diabetes care
  • Examination of market reports and white papers from industry associations related to healthcare and nutrition

Primary Research

  • Interviews with clinical nutritionists and diabetes care specialists in UAE hospitals
  • Surveys conducted with healthcare providers and dietitians to gather insights on patient management
  • Focus group discussions with diabetes patients to understand their nutritional needs and preferences

Validation & Triangulation

  • Cross-validation of findings through multiple expert interviews and stakeholder feedback
  • Triangulation of data from clinical studies, patient surveys, and market trends
  • Sanity checks through consultations with healthcare policy experts and nutrition researchers

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the total addressable market based on national health expenditure and diabetes prevalence rates
  • Segmentation of the market by service type, including outpatient care, dietary consultations, and educational programs
  • Incorporation of demographic trends and lifestyle changes affecting diabetes management in the UAE

Bottom-up Modeling

  • Collection of data from leading clinical nutrition service providers on patient volumes and service pricing
  • Estimation of market share based on the number of registered dietitians and nutritionists in the UAE
  • Volume x cost analysis for various diabetes care services offered in the region

Forecasting & Scenario Analysis

  • Utilization of time-series analysis to project future market growth based on historical data
  • Scenario modeling based on potential changes in healthcare policies and diabetes prevalence rates
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Clinical Nutrition Services120Clinical Nutritionists, Dietitians
Diabetes Care Programs100Healthcare Providers, Diabetes Educators
Patient Dietary Management80Diabetes Patients, Caregivers
Health Policy Impact60Health Policy Makers, Public Health Officials
Market Trends in Nutrition90Nutrition Researchers, Academic Experts

Frequently Asked Questions

What is the current value of the UAE Clinical Nutrition Diabetes Care Market?

The UAE Clinical Nutrition Diabetes Care Market is valued at approximately USD 14 million, reflecting a significant growth driven by the increasing prevalence of diabetes and rising healthcare expenditures in the region.

What factors are driving the growth of the UAE Clinical Nutrition Diabetes Care Market?

Which cities are the primary markets for clinical nutrition diabetes care in the UAE?

What are the main product types in the UAE Clinical Nutrition Diabetes Care Market?

Other Regional/Country Reports

Indonesia Clinical Nutrition Diabetes Care Market

Malaysia Clinical Nutrition Diabetes Care Market

KSA Clinical Nutrition Diabetes Care Market

APAC Clinical Nutrition Diabetes Care Market

SEA Clinical Nutrition Diabetes Care Market

Vietnam Clinical Nutrition Diabetes Care Market

Other Adjacent Reports

Vietnam Diabetes Pharmaceuticals Market

Malaysia Blood Glucose Monitoring Devices Market

Malaysia Nutritional Supplements Market

Qatar Enteral Nutrition Products Market

Egypt Parenteral Nutrition Solutions Market

Kuwait Diabetes Management Software Market

Philippines Telehealth Services Market

Malaysia Personalized Nutrition Market

South Africa Obesity Management Market

Vietnam Endocrine Health Products Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022